Franklin medical device company Arthrosurface has received federal clearance to market a shoulder replacement system.
The device, the OVOMotion Shoulder Arthroplasty system, is designed to minimize bone removal and in patients and increase a surgeon’s exposure to the socket of the shoulder joint.
The company announced U.S. Food and Drug Administration clearance to market the product Wednesday.
The device is intended to be used with the company’s INlay Glenoid System, which is designed to function as a socket for the shoulder joint.
“The OVOMotion Shoulder Arthroplasty System is intended to be the first of a three-element modular stemless system that will ultimately allow surgeons to intra-operatively choose between stemless, traditional and reverse options,” CEO Steke Ek said.
